ACTA1 and cancer: We recently demonstrated that LYVE-1+ PvTAMs orchestrate the formation of a pro-angiogenic niche with a population of pericyte-like mesenchymal cells displaying both cancer associated fibroblast (CAF) and pericyte markers (PDGFRαlow PDGFRβ+NG2+desmin+αSMA+) [11].